At a glance
Moderate Complexity
This grant is designed to support research into how certain drugs, known as incretin mimetics, affect cancer risk. These drugs are typically used for conditions like diabetes and weight loss, but this grant focuses on understanding their long-term impact on cancer. The goal is to encourage studies that explore the biological mechanisms behind these effects.
Who it's for: This grant is open to a wide range of applicants, including nonprofits, government entities, small businesses, and educational institutions. Researchers and scientists with expertise in studying the effects of incretin mimetics on cancer risk are particularly encouraged to apply.
More details
Likely Disqualifiers
- Proposing a clinical trial
- Not focusing on cancer risk mechanisms
- Lack of expertise in incretin mimetics
- Ineligible organization type
What You May Need
- Detailed research proposal
- Budget plan
- Organizational eligibility documentation
- Research team bios
- Past research experience documentation
- Letters of support or collaboration
- Institutional Review Board (IRB) approval
- Data management plan
Cautions
- Clinical trials are not allowed
- Focus must be on cancer risk, not other outcomes
- Ensure all eligibility criteria are met
Generated from official source details for readability